Merck & Co., Inc. (BMV:MRK)

Mexico flag Mexico · Delayed Price · Currency is MXN
1,918.00
+0.22 (0.01%)
Last updated: Jan 20, 2026, 12:57 PM CST
-6.76%
Market Cap4.78T
Revenue (ttm)1.18T
Net Income (ttm)349.13B
Shares Outn/a
EPS (ttm)138.59
PE Ratio13.68
Forward PE19.44
Dividend61.71 (3.22%)
Ex-Dividend DateDec 15, 2025
Volume368
Average Volume1,753
Open1,907.75
Previous Close1,917.78
Day's Range1,907.75 - 1,918.00
52-Week Range1,425.00 - 2,097.01
Beta0.30
RSI53.56
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.